Citation Impact
Citing Papers
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Interferon- γ Control of EBV-Transformed B Cells: A Role for CD8 + T Cells That Poorly Kill EBV-Infected Cells
2002
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
2009 StandoutNobel
Human Cytotoxic T Lymphocyte Responses to Live Attenuated 17D Yellow Fever Vaccine: Identification of HLA-B35-Restricted CTL Epitopes on Nonstructural Proteins NS1, NS2b, NS3, and the Structural Protein E
2002
CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses
2001
Hepatitis C Virus Infection
2001 Standout
Vaccine strategies against Epstein‐Barr virus‐associated diseases: lessons from studies on cytotoxic T‐cell‐mediated immune regulation
1999
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
Immunotherapy of Hematologic Malignancy
2003
Human CD8+ T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells
2001
HIV vaccines 1983–2003
2003
Prolonged Activation of Virus-Specific CD8+T Cells after Acute B19 Infection
2005
Lack of Epstein-Barr virus- and HIV-specific CD27− CD8+ T cells is associated with progression to viral disease in HIV-infection
2002
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Skewed maturation of memory HIV-specific CD8 T lymphocytes
2001 Nature
CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained
2000
Loss of CD28 expression on CD8+ T cells is induced by IL-2 receptor γ chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis
2000
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
2001 StandoutScience
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Interplays between mouse mammary tumor virus and the cellular and humoral immune response
1999
Epstein-Barr virus: exploiting the immune system
2001 Standout
Epstein-Barr Virus Transactivates the Human Endogenous Retrovirus HERV-K18 that Encodes a Superantigen
2001
A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals
1999 StandoutNobel
Two cases of chronic active Epstein–Barr virus infection in which EBV‐specific cytotoxic T lymphocyte was induced after allogeneic bone marrow transplantation
2008
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Differential Cd4+ and Cd8+ T–Cell Responsiveness in Hepatitis C Virus Infection
2001
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Systemic Lupus Erythematosus
2011 Standout
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
1999
Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses
2002
EBV-Infected B Cells in Infectious Mononucleosis
2000
Helping the CD8+ T-cell response
2004
Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus
2002
Analysis and Separation of Residues Important for the Chemoattractant and Antimicrobial Activities of β-Defensin 3
2008 StandoutNobel
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Quantitative and Qualitative Assessment of Human Immunodeficiency Virus Type 1 (HIV‐1)–Specific CD4+T Cell Immunity togagin HIV‐1–Infected Individuals with Differential Disease Progression: Reciprocal Interferon‐γ and Interleukin‐10 Responses
2001
Advances in understanding immunologic control of HIV infection
2004
Infection in Solid-Organ Transplant Recipients
2007 Standout
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Systemic T cell expansion during localized viral infection
1999
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
2008
Visual Demonstration of Hepatitis C Virus–Specific Memory Cd8+ T–Cell Expansion in Patients With Acute Hepatitis C
2001
Epstein–Barr Virus Infection
2000 Standout
Identification of Naive or Antigen-Experienced Human CD8+ T Cells by Expression of Costimulation and Chemokine Receptors: Analysis of the Human Cytomegalovirus-Specific CD8+ T Cell Response
2002
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
1998 Standout
A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers
1999
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Defective Control of Latent Epstein-Barr Virus Infection in Systemic Lupus Erythematosus
2004
Epitope-specific Evolution of Human CD8+ T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection
2002
Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated Diseases
2000
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells
2000
An inverse relationship between T cell receptor affinity and antigen dose during CD4+T cell responsesin vivoandin vitro
1999
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Recombinant modified vaccinia virus Ankara–simian immunodeficiency virusgag polelicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer
1998
Memory CD8 T-Cell Differentiation during Viral Infection
2004
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
1999 StandoutScience
HIV Antigens Can Induce TGF-β1-Producing Immunoregulatory CD8+ T Cells
2002
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
2001 StandoutScience
Evolution of the immune system in humans from infancy to old age
2015 Standout
The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses
1998
Clonal Expansions in Acute EBV Infection Are Detectable in the CD8 and not the CD4 Subset and Persist with a Variable CD45 Phenotype
2000
Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice
2002 StandoutNobel
Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8+ Killer T Cells
2001 StandoutNobel
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
EBV-Specific CD8+ T Cell Memory: Relationships Between Epitope Specificity, Cell Phenotype, and Immediate Effector Function
2001
CD8+ T-cell selection, function, and death in the primary immune response in vivo
2000
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Defective CTLA-4 cycling pathway in Chediak–Higashi syndrome: A possible mechanism for deregulation of T lymphocyte activation
1999
Quantitative analysis of hepatitis C virus-specific CD8+T cells in peripheral blood and liver using peptide-MHC tetramers
1999
Yellow fever 17D as a vaccine vector for microbial CTL epitopes
2005 StandoutNobel
Characteristics of virus-specific CD8+T cells in the liver during the control and resolution phases of influenza pneumonia
1998 Nobel
The Importance of Exogenous Antigen in Priming the Human CD8+ T Cell Response: Lessons from the EBV Nuclear Antigen EBNA1
2000
The BZLF1 Homolog of an Epstein-Barr-Related γ-Herpesvirus Is a Frequent Target of the CTL Response in Persistently Infected Rhesus Macaques
2006
Maintenance of Large Numbers of Virus-Specific CD8+ T Cells in HIV-Infected Progressors and Long-Term Nonprogressors
2000
Sustained Dysfunction of Antiviral CD8+T Lymphocytes after Infection with Hepatitis C Virus
2001
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Broad, Intense Anti-Human Immunodeficiency Virus (HIV) Ex Vivo CD8+Responses in HIV Type 1-Infected Patients: Comparison with Anti-Epstein-Barr Virus Responses and Changes during Antiretroviral Therapy
1999
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation
2003
Post-Transplant Lymphoproliferative Disorders
2004
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function
2000
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+T cells
2000 StandoutNobel
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Differential Immunogenicity of Epstein-Barr Virus Latent-Cycle Proteins for Human CD4+T-Helper 1 Responses
2001
Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans
2002 StandoutNobel
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection
2002
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells
2001 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
2000
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Cellular Responses to Viral Infection in Humans: Lessons from Epstein-Barr Virus
2007
Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses
2012 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of N. E. Annels being referenced
Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo
1998